Eva M. Moros-Sierra - Publications

External validation of population pharmacokinetic models of adalimumab in adult patients with inflammatory bowel disease: towards model-informed precision dosing.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: January 22, 2026

Translation and psychometric evaluation of the Spanish version of the Inflammatory Bowel Disease Knowledge (IBD-KNOW) questionnaire.

Journal: Gastroenterologia y hepatologia

Published: August 21, 2025

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 29, 2024

HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.

Journal: Inflammatory bowel diseases

Published: March 24, 2023

NSAID-induced ischemic colitis.

Journal: Revista espanola de enfermedades digestivas

Published: January 24, 2022

Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control.

Journal: Gastroenterologia y hepatologia

Published: May 09, 2021

Use of double-layered covered esophageal stents in post-surgical esophageal leaks and esophageal perforation: Our experience.

Journal: Gastroenterologia y hepatologia

Published: January 11, 2021

Cytomegalovirus-associated pseudotumor mimicking ceccum carcinoma in a non inmunocompromised patient.

Journal: Gastroenterologia y hepatologia

Published: January 23, 2020

The safety of deep sedation with propofol controlled by the endoscopist in endoscopic retrograde cholangiopancreatography (ERCP): a prospective study in a tertiary hospital.

Journal: Revista espanola de enfermedades digestivas

Published: February 10, 2018